High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapy

Cancer mortality in Europe, 1990-92.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995

Trends of skin cancer in the Canton of Vaud, 1976-92.

British journal of cancer·1995

Pancreatitis and the risk of pancreatic cancer.

Pancreas·1995

Influence of some covariates on the reproducibility of an Italian semi-quantitative food frequency questionnaire.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995

Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

Journal of epidemiology and community health·1995

HIV transmission and Kaposi's sarcoma among European women.

AIDS (London, England)·1995

Real-world outcomes of first-line pembrolizumab monotherapy among dMMR/MSI-H advanced or recurrent endometrial cancer patients in the United States.

Gynecologic oncology·2026

Platinum resistant ovarian cancer - No longer a graveyard for drug development.

Gynecologic oncology·2026

Molecular biomarkers in uterine sarcomas: a review of reviews with genomic data integration.

Gynecologic oncology·2026

Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.

Gynecologic oncology·2026

Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort.

Gynecologic oncology·2026

Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.

Gynecologic oncology·2026

Optimizing management strategies for T4b esophageal cancer: the role of TEVAR in multimodal treatment approaches.

Scandinavian journal of gastroenterology·2026

Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

Asia-Pacific journal of clinical oncology·2026

[Efficacy of bidirectional switching therapy between adrenal ablation and adrenalectomy in patients with primary aldosteronism].

Zhonghua yi xue za zhi·2026

[Analysis of efficacy and prognostic factors of neoadjuvant chemoradiotherapy in locally advanced mid-low rectal cancer patients with RAS gene mutation].

Zhonghua yi xue za zhi·2026

[Expert consensus on co-ablation therapy for the perioperative management of bone and soft tissue tumors].

Zhonghua nei ke za zhi·2026

Related Experiment Videos

High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line

Related Concept Videos

Cancer mortality in Europe, 1990-92.

Trends of skin cancer in the Canton of Vaud, 1976-92.

Pancreatitis and the risk of pancreatic cancer.

Influence of some covariates on the reproducibility of an Italian semi-quantitative food frequency questionnaire.

Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

HIV transmission and Kaposi's sarcoma among European women.

Real-world outcomes of first-line pembrolizumab monotherapy among dMMR/MSI-H advanced or recurrent endometrial cancer patients in the United States.

Platinum resistant ovarian cancer - No longer a graveyard for drug development.

Molecular biomarkers in uterine sarcomas: a review of reviews with genomic data integration.

Farletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.

Prevalence of pathogenic germline variants and indications for testing in a diverse community-based endometrial cancer cohort.

Real-world clinical efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in heavily pretreated platinum-resistant ovarian cancer.

Optimizing management strategies for T4b esophageal cancer: the role of TEVAR in multimodal treatment approaches.

Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

Australian Practical Guide on the Management of Muscle-Invasive Bladder Cancer.

[Efficacy of bidirectional switching therapy between adrenal ablation and adrenalectomy in patients with primary aldosteronism].

[Analysis of efficacy and prognostic factors of neoadjuvant chemoradiotherapy in locally advanced mid-low rectal cancer patients with RAS gene mutation].

[Expert consensus on co-ablation therapy for the perioperative management of bone and soft tissue tumors].

Related Experiment Videos

High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line...

Related Concept Videos

Related Articles

High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line